SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank100
3Y CAGR+82.7%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+82.7%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
6.1x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $62.23M | +606.7% |
| 2024 | $8.81M | +313.8% |
| 2023 | $-4.12M | -140.4% |
| 2022 | $10.20M | +372.0% |
| 2021 | $-3.75M | -754.4% |
| 2020 | $-439000.00 | -40.3% |
| 2019 | $-313000.00 | - |